Aldeyra Therapeutics Inc (ALDX)
NASDAQ
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -70.043 | -64.418 | -55.854 | -71.306 | -47.275 | -36.511 | -29.933 | -22.78 |
Return on Equity (%) | -80.377 | -72.949 | -61.628 | -90.315 | -69.807 | -43.564 | -34.773 | -27.727 |
Return on Invested Capital (%) | -76.401 | -70.782 | -62.427 | -82.826 | -53.823 | -38.482 | -32.379 | -29.955 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | 1.722 | 2.069 | 3.3 | 1.678 | 1.539 | 3.542 | 2.579 | 2.037 |
Earnings Per Share | -1.487 | -1.167 | -1.482 | -2.123 | -0.971 | -0.995 | -1.059 | -0.638 |
Cash Per Share | 0.955 | 1.046 | 1.804 | 1.55 | 2.014 | 3.956 | 2.466 | 2.428 |
Working Capital Per Share | 1.816 | 2.122 | 3.288 | 2.173 | 1.827 | 3.805 | 2.829 | 2.134 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | -1.487 | -1.167 | -1.482 | -2.168 | -0.984 | -0.995 | -1.059 | -0.638 |
EBITDA Per Share | -1.487 | -1.167 | -1.482 | -2.168 | -0.984 | -0.995 | -1.059 | -0.638 |
Free Cash Flow Per Share | -1.489 | -1.168 | -1.475 | -2.126 | -0.973 | -0.999 | -1.063 | -0.643 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 12,58M | 19,14M | 26,24M | 28,66M | 38,67M | 58,08M | 58,56M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 58,56M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 310,85M |
Ratio cours/bénéfice | -8,65 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 2,27 |
Ratio prix/valeur comptable | 2,71 |
Rendement de dividende | - |
Actions en circulation | 59,55M |
Volume moyen (1 semaine) | 623,52k |
Volume moyen (1 mois) | 429,3k |
Variation sur 52 semaines | 57,14% |
Plus haut sur 52 semaines | 6,5476 |
Plus bas sur 52 semaines | 2,71 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales